Releaf is a London-based medical cannabis clinic, licensed to prescribe and dispense cannabis-based prescription medicines (CBPMs) in the United Kingdom.
After UK legalisation of medical cannabis in November 2018, Releaf Dispensary Ltd, founded by Mason Soiza, was incorporated on 10 May 2022. Buoyed by a ã1.5m funding round in 2023, Releaf developed a health technology platform to ease access to cannabis-based prescription medicines (CBPMs) for patients.
Releaf has conducted surveys and organised campaigns to inform medical professionals and to promote broader awareness among potential patients about the CBPMs space including through celebrity users, promotion of CBPM ID cards, and information about how CBPMs might be consumed.
Releaf is a member of the UK's Cannabis Industry Council.
Chloe Durrington was the first patient in the UK to be prescribed by Releaf with cannabis flower, which was grown legally for commercial sale by Glass Pharms.
In September 2025, Releaf was shortlisted in four categories at the Growing Business Awards 2025 and was awarded Young Company Of The Year. The company also acquired the domain name Releaf.com for ã110,000 in the same month. In October 2025, the company expanded into the German medical cannabis market.
In January 2026, Releaf launched a 24/7 legal helpline to provide guidance for UK patients with medical cannabis prescriptions.
Releaf reported issued share capital of ã37,323.83 as of 28 Oct 2025. The companyâÂÂs most recent accounts reported total assets of ã5.61 million with 49 employees.